hifibio-logo
  • About
  • Pipeline
  • DIS® Platform
  • Partnering
  • News
  • Join Us

News

  • About
    • Company Overview
    • Leadership
    • Scientific Advisory Board
    • Board of Directors
    • Scientific Founders
    • Contact
  • Pipeline
    • Overview
    • Programs
      • EMUNKITUG (HFB200301)
      • HFB200603
      • NUVUSTOTUG (HFB301001)
      • HFB200604
      • HFB3024
  • DIS® Platform
  • Partnering
    • Partnerships
    • Open-Innovation Hub
  • News
  • Join Us

Latest News

Apr 29, 2025

HiFiBiO Therapeutics to Present Preclinical Data for A Novel Immunology Antibody at the 2025 Annual Meeting of the Clinical Immunology Society 

All  Filter By:

Oct 15, 2018

HiFiBiO Therapeutics Acquires H-Immune Therapeutics

Oct 2, 2018

Research Collaboration to Develop Technology for the Treatment of Cancer

Jul 30, 2018

HiFiBiO Therapeutics Signs Multi-Target Antibody Discovery Agreement with Takeda

May 16, 2018

HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders

Logo-RGB-72
Oct 12, 2017

HiFiBiO and collaborators publish single-cell microfluidics work in Nature Biotechnology

< 1 … 12 13 14 15 16 17 >

oncoverity logo

© 2025 HiFiBiO Therapeutics, Inc.
All Rights Reserved.

Contact

contact@hifibio.com 237 Putnam Ave
Cambridge, MA 02139

Follow Us

Legal

Privacy Policy
Disclaimer
logo
  • About
    • Company Overview
    • Leadership
    • Scientific Advisory Board
    • Board of Directors
    • Scientific Founders
    • Contact
  • Pipeline
    • Overview
    • Programs
      • EMUNKITUG (HFB200301)
      • HFB200603
      • NUVUSTOTUG (HFB301001)
      • HFB200604
      • HFB3024
  • DIS® Platform
  • Partnering
    • Partnerships
    • Open-Innovation Hub
  • News
  • Join Us